Studies found that the high expression of UTX in colon cancer tissue (Tang et al. 2019), while the loss of UTX led to malignant progression of lymphoma and UTX mutations affected the drug sensitivity of cytarabine (Li et al. 2018). The gene discussed is KDM6A; the disease is malignant colon neoplasm.